“This vaccine will be much easier to transport, store and distribute in a place like Indonesia, where we have many islands,” he said.
Biotechnology company Novavax said Monday that Indonesia has given the world’s first emergency use authorization for its COVID-19 vaccine, which uses a different technology than current shots, the AP reports.
The vaccine is easier to store and transport than some other shots, which could allow it to play an important role in boosting supplies in poorer countries around the world.
The two-dose Novavax vaccine is made with lab-grown copies of the spike protein that coats the coronavirus. That’s very different from widely used mRNA vaccines such as Pfizer and Moderna that deliver genetic instructions for the body to make its own spike protein.
The emergency authorization of the vaccine is a “very important step” for Indonesia’s COVID-19 vaccination program, Indonesian epidemiologist Dicky Budiman said.
© Copyright LaPresse